This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 P Libby , PM Ridker & A Maseri (2002) Inflammation and atherosclerosis. Circulation 105, 1411–1415.
2 T Pischon , FB Hu , KM Rexrode , et al. (2008) Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis 197, 392–399.
3 P Manning , WHF Sutherland , MM McGrath , et al. (2008) Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity 16, 2046–2052.
4 D El-Khoury , N Hwaila , V Frochet , et al. (2010) Postprandial metabolic and hormonal responses of obese dyslipidemic subjects with metabolic syndrome to test meals, rich in carbohydrate, fat or protein. Atherosclerosis 210, 307–313.
5 D Giugliano , A Ceriello , K Esposito , et al. (2006) The effects of diet on inflammation. J Am Coll Cardiol 48, 677–685.
6 PJ Nestel , S Pally , GL MacIntosh , et al. (2012) Circulating inflammatory and atherogenic biomarkers are not increased following single meals of dairy foods. Eur J Clin Nutr 66, 25–31.
7 AM Bernstein , Q Sun , FB Hu , et al. (2010) Major dietary protein sources and risk of coronary heart disease in women. Circulation 122, 859–860.
8 SS Soedehma-Mutha , EL Ding , WK Al-Delaimy , et al. (2011) Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose–response meta-analysis of prospective cohort studies. Am J Clin Nutr 93, 158–163.
9 RA Goldbohm , AMJ Chorus & D Garre (2011) Dairy consumption and 10-y total and cardiovascular mortality: a prospective cohort study in the Netherlands. Am J Clin Nutr 93, 615–627.
10 PJ Nestel (2012) Editorial: the changing face of the dairy-cardiovascular risk paradox. Curr Opin Lipidol 23, 1–3.
11 E Warensjo , J-H Jansson , T Cederhol , et al. (2010) Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective matched case–control study. Am J Clin Nutr 92, 194–201.
13 PC Elwood , JE Pickering , DI Givens , et al. (2010) The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids 45, 925–939.
14 S Liu , HK Choi & E Ford (2006) A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care 29, 1578–1584.
15 PJ Meikle , G Wong , D Tsorotes , et al. (2011) Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 31, 2723–2732.
16 TA Mori , KD Croft , JB Puddey , et al. (1999) An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography mass spectrometry. Anal Biochem 268, 117–125.
17The Emerging Risk Factor Collaboration (2010) C-reactive protein and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375, 132–140.
18Heart Protection Study Collaborative Group (2011) C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study. Lancet 377, 469–476.
19 M Cesari , WJH Pennix , AB Newman , et al. (2003) Inflammatory markers and onset of cardiovascular events. Circulation 108, 2317–2322.
20 I Tzoulaki , GD Murray , AJ Lee , et al. (2005) C-reactive protein, interleukin-6 and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112, 976–983.
21 J-P Empana , F Canoui-Poitrine , G Luc , et al. (2008) Contribution of novel biomarkers to incident acute coronary syndrome: the PRIME Study. Eur Heart J 29, 1966–1974.
22 RC Hoogveen , A Morrison , E Boerwinkle , et al. (2005) Plasma MCP-1 level and risk for peripheral atherosclerosis and incident coronary heart disease: Atherosclerosis Risk in Communities Study. Atherosclerosis 183, 301–307.
24 KR Kelly , JM Haus , TPJ Solomon , et al. (2011) A low-glycemic index diet and exercise intervention reduces TNFα in isolated mononuclear cells in older, obese adults. J Nutr 141, 1089–1094.
26 XC Jiang , F Paultre , TA Pearson , et al. (2000) Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol 20, 2614–2618.
27 JC Nelson , XC Jiang , I Tabas , et al. (2006) Plasma sphingomyelin and subclinical atherosclerosis findings from the multi-ethnic study of atherosclerosis. Am J Epidemiol 163, 903–912.
28 C Stegemann , I Drozdov , J Shalhoub , et al. (2011) Comparative lipidomics profiling of human atherosclerotic plaques. Circ Cardiovasc Genet 4, 232–242.
29 DJ Bolin & A Jonas (1996) Sphingomyelin inhibits the lecithin cholesterol acyl transferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. J Biol Chem 271, 1915–1918.
30 O Skaff , DI Pattison & MJ Davies (2008) The vinyl ether linkages of plasmalogens are favoured targets for the myeloperoxidase-derived oxidants: a kinetic study. Biochemistry 47, 8237–8245.
31 C Meisinger , J Baumert , N Khuseyinova , et al. (2005) Plasma oxidised low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 112, 651–657.
32 RA Stancliffe , T Thorpe & MB Zemel (2011) Dairy attenuates oxidative and inflammatory stress in metabolic syndrome. Am J Clin Nutr 94, 422–430.
33 N Panagiotacos , CH Pitsavos , AD Zampelas , et al. (2010) Dairy products consumption is associated with decreased levels of inflammatory markers related to cardiovascular disease in apparently healthy adults. J Am Coll Nutr 29, 357–364.
34 MH Wennersberg , A Smedman , AM Turpeinen , et al. (2009) Dairy products and metabolic effects in overweight men and women: results from 6-mo intervention study. Am J Clin Nutr 90, 960–968.
35 I Sluijs , NG Forouhi , JWJ Beulens , et al. (2012) The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study. Am J Clin Nutr 96, 382–390.